The effect of different doses of maprotiline on the treatment of Iranian patients suffering from moderate MDD

How to Cite:Amanat S, Ataiean A. The effect of different doses of maprotiline on the treatment of Iranian patients suffering from moderate MDD. koomesh. 2006;8(1):e152119. doi:

Abstract

Introduction: Treatment effect of maprotiline at different doses (50-150 mg/d) as a tetracyclic antidepressant, with major effects on NEP and less anticholinergic side effects compared to some other tricyclic medications, has been compared with other medications. Given ethical and cultural differences as well as pharmacokinetic characteristics between Iranian populations, the current study was carried out to determine the effect of different doses of maprotiline in treatment of moderate MDD, its therapeutic ratio and related side effects in each dose, and also to define the effective dose of maprotiline. Materials and Methods: This quasi-experimental study was performed on the patients with moderate MDD who referred to psychiatry clinics. Thirty cases were selected from the patient with age between 25-50 years, with 20≤ BMI≤30, and without any systemic diseases. Firstly, HAMD-17 test was performed for all subjects and then they took 50mg/d of maprptiline. After two weeks, the subjects were visited again, in case of HAMD-17 < 50%, they received 25mg/d of maprotiline for another two more weeks until their depression was completely treated. Side effects were also checked at two-week intervals. Finally, the number of cured subjects, side effects and effective dose were defined. Results: 27 out of 30 patients were followed up to the end of the study. They included 15 women (55.5%) and 12 men (44.4%) with mean age of 36.2±2.3 years. In dose of 50mg/d , 5 out of 27, in dose of 75 mg/d, 11 out of 22,in dose of 100mg/d, 6 out of 11 ,in dose of 125 mg/d ,3 out of 5 and finally in dose of 150mg/d the remaining 2 patients were cured. With respect to side effects, dry mouth was seen in 8 out of 22 patients received a dose of 75 mg/d and 7 out of 11 patients given a dose of 100mg/d. A significant difference was observed between the mean effective doses in the patients with past history of depression (105 mg/d) in comparison with patients without previous history of Depression (76.5mg/d) (P-value=0.01). The mean effective dose was calculated as 78.03 mg/d. Conclusion: The highest frequency of cure was seen in doses of 75 mg/d and 100mg/d with mean of 78.03 mg/d. Furthermore, the mean effective dose in the patients with a previous history of depression was higher than those without a previous history of depression. In addition, side effects were increased with higher doses of maprotiline. Regarding the restrictions of this study such as the lower number of samples in higher doses, further studies are essential to be conducted in this field.

Keywords

Maprotiline, moderate MDD, HAMD-17, Side effect, Drug dose

ماپروتیلین، اختلال افسردگی اساسی متوسط، عارضه جانبی، مقیاس سنجش افسردگی هامیلتون (HAMD-17)، دوز دارویی

Urine Screening Outcomes in Amphetamine and Methamphetamine Use Disorder Treated with Mirtazapine: A Double-Blind Placebo-Controlled Study in Iran

Ahmad Fakhri,

Shahin Norouzi,

Siamak Baghaei,

Saeid Bitaraf,

Payam Amini,

Salem Mousavi

,et al.

Fakhri A, Norouzi S, Baghaei S, Bitaraf S, Amini P, et al. Urine Screening Outcomes in Amphetamine and Methamphetamine Use Disorder Treated with Mirtazapine: A Double-Blind Placebo-Controlled Study in Iran. Jundishapur J Nat Pharm Prod. 2026;21(2):e169777. doi: https://doi.org/10.5812/jjnpp-169777

25

Aug

2012

Evaluation of Pharmaceutical Products of St. John’s Wort Efficacy Added on Tricyclic Antidepressants in treating Major Depressive Disorder: A Double Blind Randomized Control Trial

Sirus Pakseresht,

Hatam Boustani,

Mohammad Ebrahim Azemi,

Jale Nilsaz,

Reza Babapour,

Mohammad Reza Haghdust

Pakseresht S, Boustani H, Azemi ME, Nilsaz J, Babapour R, et al. Evaluation of Pharmaceutical Products of St. John’s Wort Efficacy Added on Tricyclic Antidepressants in treating Major Depressive Disorder: A Double Blind Randomized Control Trial. Jundishapur J Nat Pharm Prod. 2012;7(3):e94151. doi: https://doi.org/10.17795/jjnpp-4318

30

Jun

2011

Major Depressive Disorder: A Comparison of a Focused Psychodynamic Psychotherapy and Pharmacotherapy

Fateh Rahmani,

Farzin Rezaei,

Marzie Nasuri

Rahmani F, Rezaei F, Nasuri M. Major Depressive Disorder: A Comparison of a Focused Psychodynamic Psychotherapy and Pharmacotherapy. Iran J Psychiatry Behav Sci. 2011;5(1):. doi:

11

Nov

2025

Examining the Effects of Mirtazapine in Reducing Dependence and Craving for Amphetamine and Methamphetamine: A Clinical Study in Addiction Treatment Patients

Ahmad Fakhri,

Shahin Norouzi,

Siamak Baghaei,

Saeid Bitaraf,

Payam Amini,

Salem Mousavi

,et al.

Fakhri A, Norouzi S, Baghaei S, Bitaraf S, Amini P, et al. Examining the Effects of Mirtazapine in Reducing Dependence and Craving for Amphetamine and Methamphetamine: A Clinical Study in Addiction Treatment Patients. Jundishapur J Nat Pharm Prod. 2025;20(4):e167514. doi: https://doi.org/10.5812/jjnpp-167514

25

Feb

2011

Effects of cognitive therapy, drug therapy and combined therapy in improvement of major depression

Nemat Sotodeh Asl,

behnamfar behnamfar,

Raheb Ghorbani

Sotodeh Asl N, behnamfar B, Ghorbani R. Effects of cognitive therapy, drug therapy and combined therapy in improvement of major depression. koomesh. 2011;13(1):e152497. doi:

Import into EndNote Import into BibTex

Share on

Comments

Number of Comments:0

Cited by

Scopus by DOI: 0
Last Update: 2 weeks ago
Scopus by Title: 1
Last Update: 2 weeks ago
Scopus by Title (Ref): 1
Last Update: 2 weeks ago
CrossRef: 0
Last Update: 3 days ago

Metrics

Ordering Reprints

Articles are published under the Creative Commons license stated on each article. No permission or royalty fee is required for uses permitted by that license. CCC handles optional bulk and customized reprint orders. Any quotation covers production and delivery services only, not copyright permission. > Request Reprints from CCC

Search Relations

Author(s):

Seyamak Amanat:[PubMed][Scholar]
Afshin Ataiean:[PubMed][Scholar]

Journal of Semnan University of Medical Sciences

Outlines

The effect of different doses of maprotiline on the treatment of Iranian patients suffering from moderate MDD

Abstract

Similar Articles

Urine Screening Outcomes in Amphetamine and Methamphetamine Use Disorder Treated with Mirtazapine: A Double-Blind Placebo-Controlled Study in Iran

Evaluation of Pharmaceutical Products of St. John’s Wort Efficacy Added on Tricyclic Antidepressants in treating Major Depressive Disorder: A Double Blind Randomized Control Trial

Major Depressive Disorder: A Comparison of a Focused Psychodynamic Psychotherapy and Pharmacotherapy

Examining the Effects of Mirtazapine in Reducing Dependence and Craving for Amphetamine and Methamphetamine: A Clinical Study in Addiction Treatment Patients

Effects of cognitive therapy, drug therapy and combined therapy in improvement of major depression

Last Update: 2 weeks ago

Last Update: 2 weeks ago

Last Update: 2 weeks ago

Last Update: 3 days ago